Literature DB >> 12873751

Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family.

E Wilder-Smith1, E K Tan, H Y Law, Y Zhao, I Ng, M C Wong.   

Abstract

The clinical spectrum of spinocerebellar ataxia 3 (SCA 3) disease is wide and varied. We describe a Chinese patient with a mutation at the SCA 3 locus with clinical features of levodopa-responsive dystonia. The family history was suggestive of being autosomally dominant. Levodopa responsiveness though rare has been described in families with features of parkinsonism. Noteworthy is the relatively late onset of disease (>40 years) possibly explained by the low number of affected alleles at 59, the usual range being from 62 to 86, with the lowest recorded number at 56. This expands the wide and varied phenotypic manifestations of SCA 3, and highlights the observation that features suggestive of levodopa-responsive dystonia (DRD) such as focal dystonia, gait difficulty with diurnal fluctuation of symptoms, and a marked response to low doses of levodopa can be presenting features of SCA 3. SCA 3 should be considered a differential diagnosis in adult patients who present with DRD phenotype and with a positive family history.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873751     DOI: 10.1016/s0022-510x(03)00129-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

Review 1.  Tremor-spectrum in spinocerebellar ataxia type 3.

Authors:  Cecilia Bonnet; Emmanuelle Apartis; Mathieu Anheim; Andre P Legrand; Jose F Baizabal-Carvallo; Anne M Bonnet; Alexandra Durr; Marie Vidailhet
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

2.  Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings.

Authors:  S M Boesch; J Müller; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

Review 3.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

Review 4.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 5.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 6.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

7.  Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.

Authors:  Juei-Jueng Lin; Chin-Song Lu; Chon-Haw Tsai
Journal:  J Neurol       Date:  2017-12-30       Impact factor: 4.849

Review 8.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 9.  Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective.

Authors:  Jia Nee Foo; Jianjun Liu; Eng-King Tan
Journal:  Hum Genet       Date:  2013-03-23       Impact factor: 4.132

Review 10.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.